All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drakarlalessa on Instagram · 7s|Watch on Instagram

This peptide influencer's claims don't match the evidence

Karla Lessa

Instagram creator

202.2K viewsView on Instagram

Quick answer

Most peptides mentioned (TB-500, SS-31, KPV) lack FDA approval and exist in regulatory gray areas, while tirzepatide is a legitimate GLP-1/GIP dual agonist approved for diabetes and obesity. The cosmetic and performance claims lack strong clinical evidence from human trials.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksTB-500 (Thymosin Beta-4)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

TB-500 (Thymosin Beta-4) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For This peptide influencer's claims don't match the evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TB-500 (Thymosin Beta-4) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this tb-500 video claims cluster

Best for searchers comparing TB-500 recovery claims with BPC-157 and broader peptide-safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "This peptide influencer's claims don't match the evidence" from Karla Lessa. We read the clip as a Peptide social video fact-checks claim about TB-500 (Thymosin Beta-4), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Most peptides mentioned (TB-500, SS-31, KPV) lack FDA approval and exist in regulatory gray areas, while tirzepatide is a legitimate GLP-1/GIP dual agonist approved for diabetes and obesity.

The reason this review is not generic is the source wording and the canonical claim label "peptides comecei a usar alguns pept deos e j estou sentindo a difere." In this clip, the useful excerpt is: "Comecei a usar alguns peptídeos e já estou sentindo a diferença no meu corpo e na minha pele." That wording changes the review because it points to TB-500 (Thymosin Beta-4) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. TB-500 (Thymosin Beta-4) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

TB-500 and SS-31 aren't approved for human consumption and may be unsafe
People who land here are usually comparing the TB-500 (Thymosin Beta-4) claim with peptideos, glow, and klow.
The strongest next step is to compare the claim with FormBlends' TB-500 (Thymosin Beta-4) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Most peptides mentioned (TB-500, SS-31, KPV) lack FDA approval and exist in regulatory gray areas, while tirzepatide is a legitimate GLP-1/GIP dual agonist approved for diabetes and obesity.

FormBlends verdict

TB-500 (Thymosin Beta-4) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the TB-500 (Thymosin Beta-4) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Most peptides mentioned (TB-500, SS-31, KPV) lack FDA approval and exist in regulatory gray areas, while tirzepatide is a legitimate GLP-1/GIP dual agonist approved for diabetes and obesity. The cosmetic and performance claims lack strong clinical evidence from human trials.
  • Only tirzepatide among the mentioned peptides has FDA approval for legitimate medical use
  • TB-500 and SS-31 aren't approved for human consumption and may be unsafe

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • TB-500 (Thymosin Beta-4) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the TB-500 (Thymosin Beta-4) guide, cost path, safety notes, and provider review before acting.

Review TB-500 (Thymosin Beta-4)

What You'll Learn

  • Only tirzepatide among the mentioned peptides has FDA approval for legitimate medical use
  • TB-500 and SS-31 aren't approved for human consumption and may be unsafe
  • Claims about skin firmness, hair shine, and muscle recovery lack strong clinical evidence
  • Tirzepatide achieved 22.5% weight loss in clinical trials but requires prescription for diabetes or obesity
  • Most cosmetic peptide benefits come from small studies or animal research, not human trials
  • Calling peptides 'intelligent messengers' is marketing language, not scientific terminology
  • Unregulated peptides sold online may be contaminated or mislabeled

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

Karla Lessa (@drakarlalessa) tells her 202,000 followers that peptides have transformed her energy, sleep, skin firmness, hair shine, body fat percentage, and muscle recovery. She specifically mentions peptides like GHK-Cu, TB-500, KPV, tirzepatide, and SS-31 as "intelligent messengers" that activate what your body already has.

The video positions these compounds as beauty and performance enhancers rather than medical treatments. But several of the peptides she mentions aren't even available legally for human use outside clinical trials.

Does the science actually support these claims?

The evidence is thin and inconsistent across the peptides she mentions. GHK-Cu shows some promise for wound healing in small studies, but the data on skin firmness and hair shine is mostly from lab studies, not human trials.

TB-500 has never been approved for human use by any major regulatory agency. The research exists only in animal studies and a handful of small human trials that don't support the recovery claims Lessa makes.

Tirzepatide is the odd one out here. It's actually FDA-approved for diabetes (Mounjaro) and obesity (Zepbound), with solid clinical data. But Lilly's SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 22.5% weight loss, not the cosmetic benefits Lessa describes.

What did she get wrong about peptide regulation?

Lessa presents these peptides as readily available wellness products, but that's misleading. Most of the compounds she mentions exist in a regulatory gray area or are outright banned for human consumption.

TB-500 is prohibited by the World Anti-Doping Agency and isn't approved by the FDA for any human use. SS-31 (elamipretide) failed its Phase III trial for primary mitochondrial myopathy in 2020 and remains experimental.

Only tirzepatide has legitimate clinical approval, and it requires a prescription for diabetes or obesity treatment. The other peptides are typically sold by compounding pharmacies or research chemical companies, not legitimate pharmaceutical channels.

What about the 'intelligent messenger' claim?

This is marketing language, not science. While peptides do act as signaling molecules in the body, calling them "intelligent messengers" anthropomorphizes basic biochemistry.

Peptides are short chains of amino acids that can bind to specific receptors and trigger cellular responses. That's not intelligence, it's lock-and-key chemistry that happens billions of times in your body every day.

The "activate what your body already has" framing is particularly misleading. Most therapeutic peptides work by either mimicking natural peptides at higher concentrations or by binding to receptors in ways your body doesn't naturally do.

What should you actually know about peptide therapy?

Legitimate peptide therapy exists, but it's far more limited than influencers suggest. Insulin is a peptide hormone that's saved millions of lives. GLP-1 agonists like semaglutide and tirzepatide are peptides with strong evidence for weight loss.

But the cosmetic and performance benefits Lessa describes aren't supported by strong human trials. Most studies on peptides for skin, hair, and muscle recovery are small, short-term, or conducted only in animals.

If you're considering peptide therapy, work with a doctor who can prescribe FDA-approved options like tirzepatide for appropriate medical conditions. Don't buy unregulated peptides online based on Instagram testimonials.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Karla Lessa · Instagram creator

202.2K views on this video

Comecei a usar alguns peptídeos e já estou sentindo a diferença no meu corpo e na minha pele. 💥Mais energia, sono de qualidade, mais firmeza na pele, cabelo com mais brilho, menor percentual de gordu

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about only tirzepatide among the mentioned peptides has fda approval for?

Only tirzepatide among the mentioned peptides has FDA approval for legitimate medical use

What does the video say about tb-500?

TB-500 and SS-31 aren't approved for human consumption and may be unsafe

What does the video say about claims about skin firmness, hair shine,?

Claims about skin firmness, hair shine, and muscle recovery lack strong clinical evidence

What does the video say about tirzepatide achieved 22.5% weight loss in clinical trials?

Tirzepatide achieved 22.5% weight loss in clinical trials but requires prescription for diabetes or obesity

What does the video say about most cosmetic peptide benefits come from small studies?

Most cosmetic peptide benefits come from small studies or animal research, not human trials

What does the video say about calling peptides 'intelligent messengers'?

Calling peptides 'intelligent messengers' is marketing language, not scientific terminology

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Karla Lessa, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.